Dynacin (Minocycline Hydrochloride Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 15, 2021 Category: Drugs & Pharmacology Source Type: news

Zilxi (Minocycline Topical Foam) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 11, 2021 Category: Drugs & Pharmacology Source Type: news

HEALTH NOTES: Antibiotics 'help treat depression'
HEALTH NOTES: Doctors in South London recruited 39 patients suffering 'treatment-resistant' depression and gave half of them the antibiotic minocycline. (Source: the Mail online | Health)
Source: the Mail online | Health - January 30, 2021 Category: Consumer Health News Source Type: news

Antibiotic may improve outcomes for depression in people with low level inflammation
(NIHR Maudsley Biomedical Research Centre) King's College London researchers have found evidence that minocycline, a widely used antibiotic with anti-inflammatory properties, gave greater improvement in depressive symptoms in patients with treatment resistant depression with low-grade peripheral inflammation. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - January 27, 2021 Category: International Medicine & Public Health Source Type: news

Minolira (Minocycline Hydrochloride Extended-Release Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 14, 2021 Category: Drugs & Pharmacology Source Type: news

Expanding Treatment Options for Rosacea Expanding Treatment Options for Rosacea
A new study reports on the beneficial effects of topical minocycline on papulopustular rosacea.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2020 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Amzeeq (Minocycline Topical Foam) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 14, 2020 Category: Drugs & Pharmacology Source Type: news

Zilxi (Minocycline Topical Foam) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 4, 2020 Category: Drugs & Pharmacology Source Type: news

FDA Approves Zilxi (minocycline) Topical Foam for the Treatment of Rosacea
BRIDGEWATER, N.J., May 29, 2020 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the“Company”), a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 29, 2020 Category: Drugs & Pharmacology Source Type: news

Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer's disease: the MADE Phase II, three-arm RCT
Minocycline is an anti-inflammatory drug and protects against the toxic effects of β-amyloid in vitro and in animal models of Alzheimer's disease. To the best of our knowledge, no randomised placebo-controlled clinical trials in patients with Alzheimer's disease looking at the efficacy and tolerability of minocycline have been carried out. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 28, 2020 Category: Consumer Health News Source Type: news

Minocycline Foam Promising Against Rosacea Minocycline Foam Promising Against Rosacea
The new topical minocycline 1.5% foam FMX103 from Foamix Pharmaceuticals appears effective against moderate-to-severe papulopustular rosacea, according to two randomized trials.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 12, 2020 Category: Allergy & Immunology Tags: Dermatology News Source Type: news

Two More Alzheimer's Drug Candidates Fail Two More Alzheimer's Drug Candidates Fail
The BACE inhibitor lanabecestat and the antibiotic minocycline failed to slow cognitive decline in randomized controlled trials.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - December 9, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

How Is Hidradenitis Suppurativa Treated?
Discussion Hidradenitis suppurativa (HS) is a recurrent, chronic inflammatory disease of the hair follicles particularly in the apocrine gland-bearing areas of the axilla, inguinal, perianal, mammary and inframammary areas. Onset is usually after puberty, in the early 20s. It is more common in females than males. Prevalence is estimated to be 0.05- 4.1%. It can be associated with premature adrenarche, metabolic syndrome and obesity. The lesions are often pruritic, painful, and with malodorous purulent drainage. It often begins with comedomes and tender nodules, and can easily progress to painful abscesses with purulent f...
Source: PediatricEducation.org - November 25, 2019 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Amzeeq (Minocycline Topical Foam) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 30, 2019 Category: Drugs & Pharmacology Source Type: news

First Topical Form of Minocycline for Acne
FDA Clears First Topical Form of Minocycline for Acne (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 22, 2019 Category: General Medicine Source Type: news

FDA Clears First Topical Form of Minocycline for Acne FDA Clears First Topical Form of Minocycline for Acne
Minocycline topical foam (Amzeeq) is for the treatment of inflammatory lesions of nonnodular moderate to severe acne vulgaris in adults and children aged 9 years or older.FDA Approvals (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - October 21, 2019 Category: Primary Care Tags: Dermatology News Alert Source Type: news

FDA Approves Amzeeq (minocycline) Topical Foam for the Treatment of Moderate to Severe Acne
REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 18, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the“Company”), a specialty pharmaceutical company, today announced that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 18, 2019 Category: Drugs & Pharmacology Source Type: news

Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea
REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - October 17, 2019 Category: Drugs & Pharmacology Source Type: news

Medical News Today: Can minocycline help treat rheumatoid arthritis?
Minocycline is an antibiotic that can reduce inflammation. Minocycline can relieve the symptoms of rheumatoid arthritis (RA), but newer treatments are more common options. Learn about minocycline and other treatments for RA here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 11, 2019 Category: Consumer Health News Tags: Rheumatoid Arthritis Source Type: news

Medical News Today: Common acne drug could prevent artery hardening
Scientists have identified the mechanism that causes artery hardening and have shown that the antibiotic minocycline can prevent the process in rats. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 11, 2019 Category: Consumer Health News Tags: Vascular Source Type: news

Acne drug could prevent deadly heart attacks and strokes
Scientists from the University of Cambridge were surprised to discover molecules in the antibiotic minocycline block the pathway that leads to deposits in the circulatory system. (Source: the Mail online | Health)
Source: the Mail online | Health - June 11, 2019 Category: Consumer Health News Source Type: news

Clinical features and antimicrobial susceptibility profiles of culture-proven neonatal sepsis in a tertiary children's hospital, 2013 to 2017.
Neonatal sepsis (NS) remains a major cause of morbidity and mortality in neonates, but data on the etiology and antibiotic susceptibility patterns of pathogens are limited. The aim of this study was to analyze the clinical characteristics, risk factors, and the antibiotic susceptibility patterns of pathogenic microbes associated with NS at a tertiary children's hospital in Shanghai, China. Most isolates of Gram-positive bacteria were sensitive to vancomycin, linezolid, minocycline and tigecycline, of which more than 90% were resistant to penicillin. Most isolates of Gram-negative bacteria were sensitive to amikacin and imi...
Source: Current Awareness Service for Health (CASH) - May 29, 2019 Category: Consumer Health News Source Type: news

Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne
REHOVOT, Israel, and BRIDGEWATER, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 7, 2019 Category: Drugs & Pharmacology Source Type: news

Minocycline for Acne Changes Skin Microbiota
(MedPage Today) -- Findings in pilot study may explain adverse effects of antibiotic therapy in acne (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - February 16, 2019 Category: Dermatology Source Type: news

Minocycline Reduce Synaptic Pruning in Schizophrenia Cell Models Minocycline Reduce Synaptic Pruning in Schizophrenia Cell Models
Minocycline reduces excessive synaptic pruning in schizophrenia patient-derived cell models, suggesting that it might delay or prevent the onset of schizophrenia in some individuals, according to new research.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 13, 2019 Category: Pathology Tags: Psychiatry News Source Type: news

Antibiotic could protect against neurodegenerative diseases during aging
(eLife) An antibiotic, minocycline, can increase the lifespan of roundworms by preventing the build-up of proteins during aging, a study in the open-access journal eLife reports. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 28, 2018 Category: International Medicine & Public Health Source Type: news

Minocin Flops in Schizophrenia; Lavender Soothes Anxiety
(MedPage Today) -- News and commentary from the psychiatry world (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - October 24, 2018 Category: Psychiatry Source Type: news

Antibiotic Fails to Cut Negative Symptoms of Schizophrenia Antibiotic Fails to Cut Negative Symptoms of Schizophrenia
Adjunctive minocycline failed to ease negative symptoms or inflammatory or neuropathic processes in patients with recent-onset psychosis in what is believed to be the largest trial to date.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - October 17, 2018 Category: Psychiatry Tags: Psychiatry News Source Type: news

Woman's tongue turned BLACK and 'hairy' because of an antibiotic
Doctors in St Louis have revealed the unnamed 55-year-old's bizarre side effect was caused by minocycline, an antibiotic that was given to her to combat a wound infection. (Source: the Mail online | Health)
Source: the Mail online | Health - September 5, 2018 Category: Consumer Health News Source Type: news

Solodyn (Minocycline Hydrochloride) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 21, 2018 Category: Drugs & Pharmacology Source Type: news

Common Medications Can Cause Drug-Induced Lupus
BOSTON (CBS) – A busy mom of two young kids, Faryn Savasta of Westborough is constantly on the go. But chasing after her kids would have been impossible a few years ago. “All of a sudden I woke up one day and I felt like I couldn’t move,” she said. “My legs felt like giant rocks and I couldn’t move them.” At the time, Faryn was a newlywed and looking forward to starting a family. Instead she was depending on her husband for basic needs. “Bring me to the bathroom, help me get in and out of bed. It was shocking,” she recalled. Faryn Savasta of Westborough. (WBZ-TV) A...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - July 6, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall Local TV Lupus Source Type: news

Impax Reaches $20 Mln Deal to End Trial Over Generic Drug's Delay Impax Reaches $20 Mln Deal to End Trial Over Generic Drug's Delay
Impax Laboratories Inc has agreed to pay $20 million to consumers and insurers to resolve claims that the drugmaker entered an anticompetitive deal to delay launching a generic, cheaper version of acne medication Solodyn.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 30, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Impax reaches $20 million deal to end trial over generic drug's delay
BOSTON (Reuters) - Impax Laboratories Inc has agreed to pay $20 million to consumers and insurers to resolve claims that the drugmaker entered an anticompetitive deal to delay launching a generic, cheaper version of acne medication Solodyn. (Source: Reuters: Health)
Source: Reuters: Health - March 29, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Impax broke U.S. antitrust law by delaying generic drug, jury told
BOSTON (Reuters) - Impax Laboratories Inc went to trial on Monday over allegations by major retailers and consumers that the company agreed to delay launching a generic version of acne medication Solodyn in exchange for millions of dollars from the manufacturer. (Source: Reuters: Health)
Source: Reuters: Health - March 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Impax faces U.S. antitrust trial over generic acne drug's delay
BOSTON (Reuters) - Impax Laboratories Inc went to trial on Monday over claims by major retailers and consumers that the company agreed to delay launching a generic version of Solodyn in exchange for millions of dollars from the acne medication's manufacturer. (Source: Reuters: Health)
Source: Reuters: Health - March 12, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Traumatic brain injury: minocycline reduces microglial activation but increases neurodegeneration after TBI - Wood H.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - February 5, 2018 Category: International Medicine & Public Health Tags: TBI Source Type: news

Minocycline As an Alternative to Doxycycline for Rosacea Minocycline As an Alternative to Doxycycline for Rosacea
A new study suggests that minocycline is as effective as doxycycline in treating papulopustular rosacea; but adverse effects might relegate it to a second-line option.The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 25, 2017 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news

Antibiotic Shows Promise for Major Depression Antibiotic Shows Promise for Major Depression
Minocycline, a broad-spectrum antibiotic frequently used to treat acne, may have utility as an adjunct for treating depression, especially by improving global functioning and quality of life.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 12, 2017 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Ximino (Minocycline Hydrochloride) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 21, 2017 Category: Drugs & Pharmacology Source Type: news

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include treating resistant hepatitis C infection, a new regimen for breast cancer, evolution of non-small cell lung cancer, and minocycline for MS (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - June 3, 2017 Category: Gastroenterology Source Type: news

Old Antibiotic May Slow Conversion From CIS to MS Old Antibiotic May Slow Conversion From CIS to MS
Treatment with minocycline met the randomized controlled trial's primary endpoint, decreasing conversion vs placebo within 6 months, but between-group differences weren't sustained at 24 months.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 1, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Minocycline Might Help Prevent Progression to Multiple Sclerosis (FREE)
By the Editors The antibiotic minocycline might help prevent progression to multiple sclerosis in patients with an isolated demyelinating event, a New England Journal of … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 1, 2017 Category: Primary Care Source Type: news

Common acne medicine reduces risk of multiple sclerosis, Calgary researchers find
Millions of people already take minocycline to treat acne, but University of Calgary researchers have found the inexpensive antibiotic also helps to control multiple sclerosis. (Source: CBC | Health)
Source: CBC | Health - May 31, 2017 Category: Consumer Health News Tags: News/Canada/Calgary Source Type: news

Arestin (Minocycline Hydrochloride Microspheres) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 22, 2017 Category: Drugs & Pharmacology Source Type: news

Minolira (Minocycline Hydrochloride Extended-Release Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 19, 2017 Category: Drugs & Pharmacology Source Type: news

What Are Options for Acne Treatment?
Discussion Acne vulgaris or acne is a problem of the pilosebaceous follicle. It occurs most prominently where sebaceous glands are abundant especially the face, neck, and upper back. Sebum production increases because of androgens. Keratin and sebum clog the pores of the pilosebaceous unit causing hyperkeratosis (clogged pilosebaceous unit = clogged pores = comedomes). Propionibacterium acnes, a gram-negative anaerobe, multiplies in the sebaceous unit causing an inflammatory reaction resulting in moderate or severe acne. Skin lesions include: Comedomal acne has comedomes White heads = closed comedomes Black heads = open...
Source: PediatricEducation.org - January 16, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Minocin (Minocycline Hydrochloride Oral Suspension) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 15, 2016 Category: Drugs & Pharmacology Source Type: news

Minocin Injection (Minocycline Inj) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 15, 2016 Category: Drugs & Pharmacology Source Type: news

Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults
This Cochrane Review informed a practice changing update on Dynamed Plus. It found that antimicrobial coatings that appear to reduce risk of central venous catheter-related bloodstream infection include minocycline-rifampicin, chlorhexidine silver sulfadiazine, silver, and heparin, but antimicrobial coatings do not appear to reduce risk of sepsis or mortality (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 2, 2016 Category: Consumer Health News Source Type: news